Clinical Trials Browser

Phase 4 × INDUSTRY × Ipilimumab × Clear all

NCT04513522 2025-07-11

CheckMate 7C9

Phase 4 Completed

101 enrolled 12 charts

Kidney Neoplasms

NCT01856023 2023-12-05

PROCLIVITY02

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT02869789 2023-06-15

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Phase 4 Completed

1,041 enrolled 18 charts

Lung Neoplasms

NCT02982954 2022-11-01

CHECKMATE 920

Phase 4 Completed

211 enrolled 21 charts

Carcinoma, Renal Cell